Nymox Pharmaceutical Corporation (NYMXF)
USD 0.1
(23.3%)
USD 0.1
(23.3%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -8.77 Million USD | -32.11% |
| 2022 | -6.52 Million USD | 46.85% |
| 2021 | -12.49 Million USD | -6.67% |
| 2020 | -11.71 Million USD | 12.05% |
| 2019 | -13.11 Million USD | -25.17% |
| 2018 | -10.57 Million USD | 19.62% |
| 2017 | -13.22 Million USD | -2.85% |
| 2016 | -12.87 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q3 | -1.01 Million USD | 7.84% |
| 2023 Q4 | -5.27 Million USD | -421.46% |
| 2023 Q2 | -1.09 Million USD | 20.62% |
| 2023 Q1 | -1.38 Million USD | -182.46% |
| 2022 Q1 | -5.07 Million USD | -81.17% |
| 2022 Q2 | -1.77 Million USD | 65.1% |
| 2022 Q4 | 1.67 Million USD | 213.63% |
| 2022 FY | - USD | 46.85% |
| 2022 Q3 | -1.47 Million USD | 16.67% |
| 2021 Q4 | -2.79 Million USD | 14.95% |
| 2021 FY | - USD | -6.67% |
| 2021 Q3 | -3.29 Million USD | 0.0% |
| 2020 FY | - USD | 12.05% |
| 2019 FY | - USD | -25.17% |
| 2018 FY | - USD | 19.62% |
| 2017 FY | - USD | -2.85% |
| 2016 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 87.651% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | -47.953% |
| SQZ Biotechnologies Company | -64.14 Million USD | 86.324% |
| Evofem Biosciences, Inc. | -17.37 Million USD | 49.499% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 109.328% |
| Mesoblast Limited | -62.38 Million USD | 85.94% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -471.076% |
| Genus plc | 73.7 Million USD | 111.902% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | -32.678% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | -147.308% |
| Marizyme, Inc. | -34.28 Million USD | 74.412% |
| ContraFect Corporation | -64.99 Million USD | 86.504% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | -93.805% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -525.763% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | -231.714% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -277.482% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -1593.286% |
| Accustem Sciences Inc. | -3.74 Million USD | -134.144% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 81.811% |
| EV Biologics, Inc. | -1.26 Million USD | -592.272% |
| Q BioMed Inc. | -617.62 Thousand USD | -1320.272% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 345.577% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -1287.084% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -283.981% |
| Biomind Labs Inc. | -1.03 Million USD | -747.906% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 188.812% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | -22.492% |
| Skye Bioscience, Inc. | -13.54 Million USD | 35.25% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -489.749% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -34988.0% |
| Arch Therapeutics, Inc. | -3.88 Million USD | -125.831% |
| IMV Inc. | -35.52 Million USD | 75.306% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 44.725% |
| Curative Biotechnology, Inc. | -2.5 Million USD | -250.605% |
| GB Sciences, Inc. | -1.41 Million USD | -517.797% |
| Alpha Cognition Inc. | -9.7 Million USD | 9.619% |
| HST Global, Inc. | -5303.00 USD | -165315.802% |
| CSL Limited | 4.78 Billion USD | 100.183% |
| Halberd Corporation | -74.27 Thousand USD | -11709.529% |
| Enzolytics Inc. | -2.12 Million USD | -313.378% |
| Resverlogix Corp. | -11.74 Million USD | 25.294% |
| Affymax, Inc. | -14.29 Million USD | 38.636% |
| SYBLEU INC | -141.57 Thousand USD | -6096.184% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | -186.384% |
| argenx SE | -216.02 Million USD | 95.939% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 84.149% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 820.789% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -485.227% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 2415.465% |
| AVAX Technologies, Inc. | -6.11 Million USD | -43.506% |
| Zenith Capital Corp. | -8.6 Million USD | -1.929% |
| Genscript Biotech Corporation | -248.71 Million USD | 96.473% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -50253.022% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -258.559% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -4883.401% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 77.869% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | -203.285% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | -738.373% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 130558.061% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -401.257% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -356.658% |
| BioStem Technologies, Inc. | -7.55 Million USD | -16.129% |
| ONE Bio Corp. | 13.61 Million USD | 164.438% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -4744.054% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -326.446% |
| Agentix Corp. | -1.37 Million USD | -539.472% |
| LadRx Corporation | 412.28 Thousand USD | 2227.665% |
| Cell Source, Inc. | -4.27 Million USD | -105.312% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -2288.752% |
| Regen BioPharma, Inc. | 1.46 Million USD | 698.381% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -836.23% |
| NovAccess Global Inc. | -1.03 Million USD | -747.702% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 199.076% |
| Itoco Inc. | -1.86 Million USD | -369.343% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -2210.732% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -686.022% |
| Kadimastem Ltd | -2.62 Million USD | -234.25% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -3567.991% |
| CytoDyn Inc. | -18.02 Million USD | 51.345% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -10999.723% |
| Mobile Lads Corp. | -2.24 Million USD | -291.405% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -71631.131% |
| Qrons Inc. | -40.08 Thousand USD | -21785.681% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -1706.135% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 1763.15% |
| Rebus Holdings, Inc. | -951 Thousand USD | -822.397% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -725.981% |
| International Stem Cell Corporation | 202 Thousand USD | 4442.574% |
| Bioxytran, Inc. | -3.82 Million USD | -129.625% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -16564.134% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -256.306% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 75.544% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -19393.333% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | -220.38% |
| Neutra Corp. | -181.24 Thousand USD | -4739.804% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 56.486% |
| PureTech Health plc | -11.62 Million USD | 24.555% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | 56.483% |
| IXICO plc | -707 Thousand USD | -1140.736% |
| IntelGenx Technologies Corp. | -7.68 Million USD | -14.144% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 81.856% |
| CSL Limited | 4.73 Billion USD | 100.185% |
| Cellectis S.A. | -92.63 Million USD | 90.531% |